{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732011",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732011_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">Acebutolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Acebutolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732012",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732012_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"atenolol\" outputclass=\"int-drug\">Atenolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Atenolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732013",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732013_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">Betaxolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Betaxolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732014",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732014_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">Bisoprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Bisoprolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732015",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732015_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">Carvedilol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Carvedilol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732016",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732016_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">Celiprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Celiprolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732017",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732017_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">Lanreotide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the absorption of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"ciclosporin\" outputclass=\"int-drug\">ciclosporin</ph>. <ph outputclass=\"int-action\">Manufacturer advises adjust dose</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Lanreotide   is predicted to   decrease   the absorption of   oral   ciclosporin .  Manufacturer advises adjust dose .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciclosporin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732018",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732018_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"esmolol\" outputclass=\"int-drug\">Esmolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Esmolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732019",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732019_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"labetalol\" outputclass=\"int-drug\">Labetalol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Labetalol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732020",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732020_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">Levobunolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Levobunolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732021",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732021_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">Metoprolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Metoprolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732022",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732022_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nadolol\" outputclass=\"int-drug\">Nadolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nadolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732023",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732023_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">Nebivolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Nebivolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732024",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732024_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"oxprenolol\" outputclass=\"int-drug\">Oxprenolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Oxprenolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxprenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732025",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732025_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"pindolol\" outputclass=\"int-drug\">Pindolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Pindolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732026",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732026_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"propranolol\" outputclass=\"int-drug\">Propranolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Propranolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732027",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732027_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"sotalol\" outputclass=\"int-drug\">Sotalol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Sotalol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732028",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2#bnf_i1557280732028_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"timolol\" outputclass=\"int-drug\">Timolol</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"lanreotide\" outputclass=\"int-heading-drug\">lanreotide</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Timolol   is predicted to   increase   the risk of bradycardia when given with   lanreotide .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				}
			],
			"hasSearchLabel": " Lanreotide  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/lanreotide-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Lanreotide </title>"
			},
			"rdfs:label": "lanreotide"
		}
	]
}